Skip to main content

Early value dossiers for medical technologies

The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Estimation of Value-Based Price for Five High-Technology Medical Devices Approved by a Regional Health Technology Assessment Committee in Italy

17 Apr 2023

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Messori et al. analyzed five HTA reports of high-risk medical devices (classes IIb and III, and active implantable devices) that included cost-effectiveness data, developed in the Tuscany region. The analysis demonstrated a high level of concordance between value-based prices and actual prices, which suggests a wider application of the value-based pricing framework for high-risk medical devices, which, however, requires an adequate level of cost-effectiveness data.

Access the full-text article here.